263 related articles for article (PubMed ID: 29343520)
1. Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.
Mustachio LM; Lu Y; Kawakami M; Roszik J; Freemantle SJ; Liu X; Dmitrovsky E
Cancer Res; 2018 Feb; 78(3):587-592. PubMed ID: 29343520
[TBL] [Abstract][Full Text] [Related]
2. The ISG15-specific protease USP18 regulates stability of PTEN.
Mustachio LM; Kawakami M; Lu Y; Rodriguez-Canales J; Mino B; Behrens C; Wistuba I; Bota-Rabassedas N; Yu J; Lee JJ; Roszik J; Zheng L; Liu X; Freemantle SJ; Dmitrovsky E
Oncotarget; 2017 Jan; 8(1):3-14. PubMed ID: 27980214
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of USP18: From Biology to Pathophysiology.
Kang JA; Jeon YJ
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957626
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
Mustachio LM; Lu Y; Tafe LJ; Memoli V; Rodriguez-Canales J; Mino B; Villalobos PA; Wistuba I; Katayama H; Hanash SM; Roszik J; Kawakami M; Cho KJ; Hancock JF; Chinyengetere F; Hu S; Liu X; Freemantle SJ; Dmitrovsky E
Mol Cancer Res; 2017 Jul; 15(7):905-914. PubMed ID: 28242811
[No Abstract] [Full Text] [Related]
5. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Chen L; Li S; McGilvray I
Int J Biochem Cell Biol; 2011 Oct; 43(10):1427-31. PubMed ID: 21704181
[TBL] [Abstract][Full Text] [Related]
6. USP18-mediated protein deISGylation and its role in tuberculosis and other infectious diseases.
Qi'ao Z; Zi-Lu W; Pei-Bo L; Jian-Ping X
Yi Chuan; 2023 Nov; 45(11):998-1006. PubMed ID: 38764265
[TBL] [Abstract][Full Text] [Related]
7. USP18 - a multifunctional component in the interferon response.
Basters A; Knobeloch KP; Fritz G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30126853
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the ubiquitin protease UBP43 as an antineoplastic target.
Guo Y; Chinyengetere F; Dolinko AV; Lopez-Aguiar A; Lu Y; Galimberti F; Ma T; Feng Q; Sekula D; Freemantle SJ; Andrew AS; Memoli V; Dmitrovsky E
Mol Cancer Ther; 2012 Sep; 11(9):1968-77. PubMed ID: 22752428
[TBL] [Abstract][Full Text] [Related]
9. How USP18 deals with ISG15-modified proteins: structural basis for the specificity of the protease.
Basters A; Knobeloch KP; Fritz G
FEBS J; 2018 Mar; 285(6):1024-1029. PubMed ID: 28881486
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the specificity of USP18 toward ISG15.
Basters A; Geurink PP; Röcker A; Witting KF; Tadayon R; Hess S; Semrau MS; Storici P; Ovaa H; Knobeloch KP; Fritz G
Nat Struct Mol Biol; 2017 Mar; 24(3):270-278. PubMed ID: 28165509
[TBL] [Abstract][Full Text] [Related]
11. The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
Liu X; Lu Y; Chen Z; Liu X; Hu W; Zheng L; Chen Y; Kurie JM; Shi M; Mustachio LM; Adresson T; Fox S; Roszik J; Kawakami M; Freemantle SJ; Dmitrovsky E
Mol Cancer Res; 2021 Apr; 19(4):667-677. PubMed ID: 33380466
[TBL] [Abstract][Full Text] [Related]
12. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
[TBL] [Abstract][Full Text] [Related]
13. Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis.
Chen Z; Zheng L; Chen Y; Liu X; Kawakami M; Mustachio LM; Roszik J; Ferry-Galow KV; Parchment RE; Liu X; Andresson T; Duncan G; Kurie JM; Rodriguez-Canales J; Liu X; Dmitrovsky E
Cancer Biol Ther; 2022 Dec; 23(1):265-280. PubMed ID: 35387560
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Target ISG15 and USP18 Toward Therapeutic Applications.
Jiménez Fernández D; Hess S; Knobeloch KP
Front Chem; 2019; 7():923. PubMed ID: 32039148
[TBL] [Abstract][Full Text] [Related]
15. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
[TBL] [Abstract][Full Text] [Related]
16. Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections.
Dauphinee SM; Richer E; Eva MM; McIntosh F; Paquet M; Dangoor D; Burkart C; Zhang DE; Gruenheid S; Gros P; Behr M; Malo D
Genes Immun; 2014; 15(5):282-92. PubMed ID: 24807690
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of ubiquitin-specific protease 18 reveals substrate specificity for interferon-stimulated gene 15.
Basters A; Geurink PP; El Oualid F; Ketscher L; Casutt MS; Krause E; Ovaa H; Knobeloch KP; Fritz G
FEBS J; 2014 Apr; 281(7):1918-28. PubMed ID: 24533902
[TBL] [Abstract][Full Text] [Related]
18. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.
Ketscher L; Hannß R; Morales DJ; Basters A; Guerra S; Goldmann T; Hausmann A; Prinz M; Naumann R; Pekosz A; Utermöhlen O; Lenschow DJ; Knobeloch KP
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1577-82. PubMed ID: 25605921
[TBL] [Abstract][Full Text] [Related]
19. Screen for ISG15-crossreactive deubiquitinases.
Catic A; Fiebiger E; Korbel GA; Blom D; Galardy PJ; Ploegh HL
PLoS One; 2007 Jul; 2(7):e679. PubMed ID: 17653289
[TBL] [Abstract][Full Text] [Related]
20. USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression.
Vuillier F; Li Z; Commere PH; Dynesen LT; Pellegrini S
Sci Rep; 2019 Mar; 9(1):4066. PubMed ID: 30858391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
